USPH Earnings

U.S. Physical Therapy Reports Second Quarter 2025 Results

Published August 06, 2025 at 08:48 PM

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $26.9 million for the three months ended June 30, 2025 (“2025 Second Quarter”), an increase of $4.7 million

Related Questions

What guidance, if any, did the company provide for Q3 2025 and the full‑year outlook? Did the company’s industrial injury‑prevention segment show any material change in contribution margin? What is the outlook for clinic utilization rates and payer mix in the coming months? Are there any planned capital‑expenditure or acquisition programs that could affect future earnings? Did the company address any macro‑economic or regulatory factors that could influence its outpatient physical‑therapy business? What were the revenue growth rates and same‑store clinic growth for the quarter? How will the $26.9 million adjusted EBITDA impact USPH’s valuation and stock price? What is the cash‑conversion cycle and expected free cash flow generation from the reported results? How does the $4.7 million QoQ EBITDA growth compare to prior quarters and to peer performance? How does the reported non‑GAAP adjusted EBITDA reconcile to the GAAP net income/loss for the quarter?